pubmed-article:11373349 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C0022661 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C0242972 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:11373349 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:11373349 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:11373349 | pubmed:dateCreated | 2001-5-24 | lld:pubmed |
pubmed-article:11373349 | pubmed:abstractText | Arandomized, controlled study of 12 patients with mild chronic renal failure was designed to assess the metabolic effects of a low-protein diet supplemented (n = 6) or not (n = 6) with ketoanalogs of amino acids. The protein intake was prescribed so that both groups were isonitrogenous. The dietary survey each month included a 3-d food record and a 24-h urine collection for urea measurement. After a 4- to 6-wk equilibrium period (standard occidental diet, 1.11 g of protein and 32 kcal/kg per d), patients reduced their protein intake to reach 0.71 g of protein/kg per d during the third month. Energy intake was kept constant (31 kcal/kg per d) during the 3-mo period. Compliance to the diet was achieved after 2 mo of training. Leucine turnover measurement was performed before and at the end of the 3-mo low-protein period. There was no clinical change, whereas total body flux decreased by 8% (P < 0.05) and leucine oxidation by 18% (P < 0.05). No difference could be attributed to the ketoanalogs themselves. Thus, under sufficient energy intake, a low-protein diet is nutritionally and metabolically safe during chronic renal failure. The nitrogen-sparing effect of a low-protein diet is still present during mild chronic renal insufficiency. | lld:pubmed |
pubmed-article:11373349 | pubmed:language | eng | lld:pubmed |
pubmed-article:11373349 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11373349 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11373349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11373349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11373349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11373349 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11373349 | pubmed:month | Jun | lld:pubmed |
pubmed-article:11373349 | pubmed:issn | 1046-6673 | lld:pubmed |
pubmed-article:11373349 | pubmed:author | pubmed-author:BernhardJJ | lld:pubmed |
pubmed-article:11373349 | pubmed:author | pubmed-author:LavilleMM | lld:pubmed |
pubmed-article:11373349 | pubmed:author | pubmed-author:FouqueDD | lld:pubmed |
pubmed-article:11373349 | pubmed:author | pubmed-author:BeaufrèreBB | lld:pubmed |
pubmed-article:11373349 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11373349 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:11373349 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11373349 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11373349 | pubmed:pagination | 1249-54 | lld:pubmed |
pubmed-article:11373349 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:meshHeading | pubmed-meshheading:11373349... | lld:pubmed |
pubmed-article:11373349 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11373349 | pubmed:articleTitle | Adaptive response to a low-protein diet in predialysis chronic renal failure patients. | lld:pubmed |
pubmed-article:11373349 | pubmed:affiliation | Department of Nephrology and Renal Nutrition, Hospital Edouard Herriot, Lyon, France. | lld:pubmed |
pubmed-article:11373349 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11373349 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11373349 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:11373349 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |